Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1980 Jan-Feb;53(1):27–39.

Virus synthesis and replication: reovirus vs. vaccinia virus.

W K Joklik
PMCID: PMC2595841  PMID: 6990634

Abstract

The strategies with which two viral genomes that consist of double-stranded nucleic acid express themselves in infected cells are compared. The reovirus genome comprises ten segments of double-stranded RNA, each of which is, in essence, a gene. Each is transcribed into plus-stranded RNA which has two functions: to serve as messenger RNA for the synthesis of the ten reovirus "primary" proteins, and to serve as template for the synthesis of minus-strands with which they remain associated, thereby giving rise to progeny double-stranded RNA. One of the most fascinating unsolved features of the reovirus multiplication cycle is the nature of the mechanism that ensures that each progeny virus particle contains a complete set of the ten individual genome RNA segments. The vaccinia virus genome is a linear molecule of double-stranded DNA which possesses sizable terminal redundancies (up to 7 percent, depending on the strain). The vaccinia virus multiplication cycle can be divided into a well-defined early and late period. During the early period, infecting virus particles are first uncoated to cores within which some 40-50 percent of the viral genome is transcribed. These cores are then uncoated further to naked viral DNA, a process that is mediated by protein(s) translated from the "core" messenger RNA. The overall transcription pattern in highly complex and is regulated both at the transcriptional as well as at the translational level. The most profound program changes occur at the time when DNA replication begins, when the transcription of "early" messenger RNAs, some of which are translated into "early" enzymes, gives way to that of "late" messenger RNAs, most of which are translated into structural virus components.

Full text

PDF
27

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acs G., Klett H., Schonberg M., Christman J., Levin D. H., Silverstein S. C. Mechanism of reovirus double-stranded ribonucleic acid synthesis in vivo and in vitro. J Virol. 1971 Nov;8(5):684–689. doi: 10.1128/jvi.8.5.684-689.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borsa J., Graham A. F. Reovirus: RNA polymerase activity in purified virions. Biochem Biophys Res Commun. 1968 Dec 30;33(6):895–901. doi: 10.1016/0006-291x(68)90396-3. [DOI] [PubMed] [Google Scholar]
  3. Chang C. T., Zweerink H. J. Fate of parental reovirus in infected cell. Virology. 1971 Dec;46(3):544–555. doi: 10.1016/0042-6822(71)90058-4. [DOI] [PubMed] [Google Scholar]
  4. Cooper J. A., Moss B. Transcription of vaccinia virus mRNA coupled to translation in vitro. Virology. 1978 Jul 1;88(1):149–165. doi: 10.1016/0042-6822(78)90118-6. [DOI] [PubMed] [Google Scholar]
  5. Desrosiers R. C., Sen G. C., Lengyel P. Difference in 5' terminal structure between the mRNA and the double-stranded virion RNA of reovirus. Biochem Biophys Res Commun. 1976 Nov 8;73(1):32–39. doi: 10.1016/0006-291x(76)90493-9. [DOI] [PubMed] [Google Scholar]
  6. Finberg R., Weiner H. L., Fields B. N., Benacerraf B., Burakoff S. J. Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A. 1979 Jan;76(1):442–446. doi: 10.1073/pnas.76.1.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garon C. F., Barbosa E., Moss B. Visualization of an inverted terminal repetition in vaccinia virus DNA. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4863–4867. doi: 10.1073/pnas.75.10.4863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. JOKLIK W. K., BECKER Y. THE REPLICATION AND COATING OF VACCINIA DNA. J Mol Biol. 1964 Dec;10:452–474. doi: 10.1016/s0022-2836(64)80066-8. [DOI] [PubMed] [Google Scholar]
  9. Johnson R. B., Jr, Soeiro R., Fields B. N. The synthesis of A-rich RNA by temperature-sensitive mutants of reovirus. Virology. 1976 Aug;73(1):173–180. doi: 10.1016/0042-6822(76)90071-4. [DOI] [PubMed] [Google Scholar]
  10. Joklik W. K. Studies on the effect of chymotrypsin on reovirions. Virology. 1972 Sep;49(3):700–715. doi: 10.1016/0042-6822(72)90527-2. [DOI] [PubMed] [Google Scholar]
  11. Kozak M., Shatkin A. J. Identification of features in 5' terminal fragments from reovirus mRNA which are important for ribosome binding. Cell. 1978 Jan;13(1):201–212. doi: 10.1016/0092-8674(78)90150-2. [DOI] [PubMed] [Google Scholar]
  12. Lai M. H., Joklik W. K. The induction of interferon by temperature-sensitive mutants of reovirus, UV-irradiated reovirus, and subviral reovirus particles. Virology. 1973 Jan;51(1):191–204. doi: 10.1016/0042-6822(73)90379-6. [DOI] [PubMed] [Google Scholar]
  13. Lazarowitz S. G., Robertson H. D. Initiator regions from the small size class of reovirus messenger RNA protected by rabbit reticulocyte ribosomes. J Biol Chem. 1977 Nov 10;252(21):7842–7849. [PubMed] [Google Scholar]
  14. Luftig R. B., Kilham S. S., Hay A. J., Zweerink H. J., Joklik W. K. An ultrastructural study of virions and cores of reovirus type 3. Virology. 1972 Apr;48(1):170–181. doi: 10.1016/0042-6822(72)90124-9. [DOI] [PubMed] [Google Scholar]
  15. Martinson H. G., Lewandowski L. J. Sequence homology studies between the double-stranded RNA genomes of cytoplasmic polyhedrosis virus, wound tumor virus, and reovirus strains 1, 2 and 3. Intervirology. 1974;4(2):91–98. doi: 10.1159/000149847. [DOI] [PubMed] [Google Scholar]
  16. McCrae M. A., Joklik W. K. The nature of the polypeptide encoded by each of the 10 double-stranded RNA segments of reovirus type 3. Virology. 1978 Sep;89(2):578–593. doi: 10.1016/0042-6822(78)90199-x. [DOI] [PubMed] [Google Scholar]
  17. Morgan C. Vaccinia virus reexamined: development and release. Virology. 1976 Aug;73(1):43–58. doi: 10.1016/0042-6822(76)90059-3. [DOI] [PubMed] [Google Scholar]
  18. Morgan E. M., Zweerink H. J. Characterization of transcriptase and replicase particles isolated from reovirus-infected cells. Virology. 1975 Dec;68(2):455–466. doi: 10.1016/0042-6822(75)90286-x. [DOI] [PubMed] [Google Scholar]
  19. Morgan E. M., Zweerink H. J. Reovirus morphogenesis. Corelike particles in cells infected at 39 degrees with wild-type reovirus and temperature-sensitive mutants of groups B and G. Virology. 1974 Jun;59(2):556–565. doi: 10.1016/0042-6822(74)90465-6. [DOI] [PubMed] [Google Scholar]
  20. Mustoe T. A., Ramig R. F., Sharpe A. H., Fields B. N. Genetics of reovirus: identification of the ds RNA segments encoding the polypeptides of the mu and sigma size classes. Virology. 1978 Sep;89(2):594–604. doi: 10.1016/0042-6822(78)90200-3. [DOI] [PubMed] [Google Scholar]
  21. Nagaya A., Pogo B. G., Dales S. Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin. Virology. 1970 Apr;40(4):1039–1051. doi: 10.1016/0042-6822(70)90150-9. [DOI] [PubMed] [Google Scholar]
  22. Nichols J. L., Bellamy A. R., Joklik W. K. Identification of the nucleotide sequences of the oligonucleotides present in reovirions. Virology. 1972 Aug;49(2):562–572. doi: 10.1016/0042-6822(72)90507-7. [DOI] [PubMed] [Google Scholar]
  23. Nichols J. L., Hay A. J., Joklik W. K. 5'-terminal nucleotide sequence of reovirus mRNA synthesized in vitro. Nat New Biol. 1972 Jan 26;235(56):105–107. doi: 10.1038/newbio235105a0. [DOI] [PubMed] [Google Scholar]
  24. Paoletti E. In vitro synthesis of a high molecular weight virion-associated RNA by vaccinia. J Biol Chem. 1977 Feb 10;252(3):866–871. [PubMed] [Google Scholar]
  25. Pelham H. R. Use of coupled transcription and translation to study mRNA production by vaccinia cores. Nature. 1977 Oct 6;269(5628):532–534. doi: 10.1038/269532a0. [DOI] [PubMed] [Google Scholar]
  26. Pennington T. H. Vaccinia virus polypeptide synthesis: sequential appearance and stability of pre- and post-replicative polypeptides. J Gen Virol. 1974 Dec;25(3):433–444. doi: 10.1099/0022-1317-25-3-433. [DOI] [PubMed] [Google Scholar]
  27. Sakuma S., Watanabe Y. Incorporation of in vitro synthesized reovirus double-stranded ribonucleic acid into virus corelike particles. J Virol. 1972 Nov;10(5):943–950. doi: 10.1128/jvi.10.5.943-950.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sanger F., Air G. M., Barrell B. G., Brown N. L., Coulson A. R., Fiddes C. A., Hutchison C. A., Slocombe P. M., Smith M. Nucleotide sequence of bacteriophage phi X174 DNA. Nature. 1977 Feb 24;265(5596):687–695. doi: 10.1038/265687a0. [DOI] [PubMed] [Google Scholar]
  29. Sarov I., Joklik W. K. Isolation and characterization of intermediates in vaccinia virus morphogenesis. Virology. 1973 Mar;52(1):223–233. doi: 10.1016/0042-6822(73)90411-x. [DOI] [PubMed] [Google Scholar]
  30. Shatkin A. J. Methylated messenger RNA synthesis in vitro by purified reovirus. Proc Natl Acad Sci U S A. 1974 Aug;71(8):3204–3207. doi: 10.1073/pnas.71.8.3204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Shatkin A. J., Sipe J. D., Loh P. Separation of ten reovirus genome segments by polyacrylamide gel electrophoresis. J Virol. 1968 Oct;2(10):986–991. doi: 10.1128/jvi.2.10.986-991.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shatkin A. J., Sipe J. D. RNA polymerase activity in purified reoviruses. Proc Natl Acad Sci U S A. 1968 Dec;61(4):1462–1469. doi: 10.1073/pnas.61.4.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Silverstein S. C., Astell C., Christman J., Klett H., Acs G. Shythesis of reovirus oligo adenylic acid in vivo and in vitro. J Virol. 1974 Mar;13(3):740–752. doi: 10.1128/jvi.13.3.740-752.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Silverstein S. C., Astell C., Levin D. H., Schonberg M., Acs G. The mechanisms of reovirus uncoating and gene activation in vivo. Virology. 1972 Mar;47(3):797–806. doi: 10.1016/0042-6822(72)90571-5. [DOI] [PubMed] [Google Scholar]
  35. Skehel J. J., Joklik W. K. Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. Virology. 1969 Dec;39(4):822–831. doi: 10.1016/0042-6822(69)90019-1. [DOI] [PubMed] [Google Scholar]
  36. Smart J. E., Ito Y. Three species of polyoma virus tumor antigens share common peptides probably near the amino termini of the proteins. Cell. 1978 Dec;15(4):1427–1437. doi: 10.1016/0092-8674(78)90066-1. [DOI] [PubMed] [Google Scholar]
  37. Smith R. E., Zweerink H. J., Joklik W. K. Polypeptide components of virions, top component and cores of reovirus type 3. Virology. 1969 Dec;39(4):791–810. doi: 10.1016/0042-6822(69)90017-8. [DOI] [PubMed] [Google Scholar]
  38. Weiner H. L., Drayna D., Averill D. R., Jr, Fields B. N. Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5744–5748. doi: 10.1073/pnas.74.12.5744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weiner H. L., Fields B. N. Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med. 1977 Nov 1;146(5):1305–1310. doi: 10.1084/jem.146.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weiner H. L., Ramig R. F., Mustoe T. A., Fields B. N. Identification of the gene coding for the hemagglutinin of reovirus. Virology. 1978 May 15;86(2):581–584. doi: 10.1016/0042-6822(78)90099-5. [DOI] [PubMed] [Google Scholar]
  41. Wittek R., Menna A., Müller H. K., Schümperli D., Boseley P. G., Wyler R. Inverted terminal repeats in rabbit poxvirus and vaccinia virus DNA. J Virol. 1978 Oct;28(1):171–181. doi: 10.1128/jvi.28.1.171-181.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wittek R., Menna A., Schümperli D., Stoffel S., Müller H. K., Wyler R. HindIII and Sst I restriction sites mapped on rabbit poxvirus and vaccinia virus DNA. J Virol. 1977 Sep;23(3):669–678. doi: 10.1128/jvi.23.3.669-678.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zweerink H. J., Joklik W. K. Studies on the intracellular synthesis of reovirus-specified proteins. Virology. 1970 Jul;41(3):501–518. doi: 10.1016/0042-6822(70)90171-6. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES